| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,957 |
5,535 |
$416K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,799 |
2,706 |
$185K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,646 |
1,562 |
$168K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,631 |
1,617 |
$143K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,268 |
1,255 |
$104K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,334 |
2,122 |
$90K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,360 |
4,182 |
$82K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,621 |
1,423 |
$77K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
638 |
598 |
$47K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
339 |
339 |
$30K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,642 |
1,558 |
$26K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,486 |
1,364 |
$25K |
| 82728 |
|
685 |
656 |
$23K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
331 |
276 |
$23K |
| 85027 |
|
799 |
776 |
$12K |
| 0001A |
|
296 |
287 |
$12K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
154 |
143 |
$11K |
| 0002A |
|
257 |
255 |
$11K |
| 96127 |
|
1,711 |
1,689 |
$6K |
| 0011A |
|
170 |
150 |
$5K |
| 99050 |
|
128 |
127 |
$5K |
| 83655 |
|
369 |
359 |
$5K |
| 83540 |
|
289 |
274 |
$5K |
| 99051 |
|
148 |
145 |
$4K |
| 99188 |
|
231 |
228 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
28 |
28 |
$3K |
| 0012A |
|
70 |
70 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
64 |
57 |
$3K |
| 97535 |
Self-care/home management training, each 15 minutes |
59 |
57 |
$2K |
| 99174 |
|
49 |
49 |
$2K |
| 0071A |
|
34 |
33 |
$1K |
| 80061 |
Lipid panel |
49 |
46 |
$1K |
| 0003A |
|
31 |
31 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
53 |
53 |
$645.22 |
| 94760 |
|
260 |
245 |
$619.26 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
25 |
24 |
$596.52 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
26 |
26 |
$555.63 |
| 0013A |
|
13 |
13 |
$538.13 |
| 90686 |
|
314 |
188 |
$456.06 |
| 90474 |
|
38 |
38 |
$393.60 |
| 90480 |
|
13 |
13 |
$332.86 |
| 84460 |
|
26 |
26 |
$331.18 |
| 84450 |
|
26 |
26 |
$322.88 |
| 82947 |
|
27 |
26 |
$254.56 |
| 81001 |
|
26 |
26 |
$173.80 |
| 81003 |
|
28 |
28 |
$123.45 |
| 99173 |
|
13 |
13 |
$25.76 |